State Policies May Prevent Cancer Patients From Using Telehealth
Privately-insured cancer patients living in states with restrictive telehealth policies were less likely to use telehealth in 2020 and 2021, a study showed.
Diagnosis & Disease Information
Oncologists Receive More EHR Messages Than Other HCPs but Spend Less Time in EHRs
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Career Careening: Was Becoming a Physician the Wrong Decision?
This article explores factors contributing to the fact that 20% of physicians are considering leaving their current practice within 2 years, as well as factors that have influenced that decision, what occupations they could pursue next, and what can be done to retain the physician workforce.
Insurance Reimbursement Challenges for Physicians
As the costs of health care continue to increase, insurance reimbursements have become even more important for medical institutions to sustain their practices and expand optimal services.
Compensation Models, Support Staff Influence Burnout in Hem/Oncs
Hematologists and oncologists are more likely to experience burnout if their compensation model is based solely on clinical productivity, a survey suggests.
Changes to MIPS Disproportionately Penalize Oncologists, Researchers Say
Oncologists participating in MIPS may be disproportionately penalized since the weight of cost measures has increased, according to researchers.
US Medical Oncologists Are Prescribing Fewer Opioids
Medical oncologists in the United States have been writing fewer prescriptions for opioids since 2017, a new study suggests.
System May Enable Precision Medicine in Cancer Care
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
Intervention Reduces Use of Systemic Therapy at End of Life in Cancer Patients
An intervention can increase serious illness conversations and reduce the use of systemic therapy at the end of life in patients with cancer.
Oncologists May Lack Understanding of Biosimilars but Use Them Anyway, Survey Suggests
US medical oncologists may lack understanding of biosimilars and have limited access to education about these products, a survey suggests.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...